ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

FAB Fusion Antibodies Plc

3.75
-0.05 (-1.32%)
May 31 2024 - Closed
Delayed by 15 minutes

Fusion Antibodies Financial Summary

The current FAB market cap is 3.58M. The company's latest EPS is GBP -0.0272 and P/E is -1.38.

Year End March 30 2023 20192020202120222023
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Total Revenue 2.18M3.9M4.17M4.8M2.9M
Operating Income -777k-1.06M-1.19M-1.35M-2.89M
Net Income -1.26M-697k-2.9M-1.2M-2.6M
Year End March 30 2023 20192020202120222023
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Total Assets 6.24M6.04M5.83M4.92M2.06M
Total Liabilities 889k1.23M1.08M1.23M939k
Total Equity 5.35M4.81M4.75M3.68M1.12M

Cash Flow

Year End March 30 2023 20192020202120222023
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Operating -1.1M-160k-1.14M-325k-1.75M
Investing -1.38M-103k-362k-257k-111k
Financing -28k-184k2.65M-55k3k
Market Cap 3.58M
Price to Earnings Ratio -1.38
Price to Sales Ratio 1.23
Price to Cash Ratio 18.75
Price to Book Ratio 3.18
Dividend Yield -

Share Statistics

Shares Outstanding 95.37M
Average Volume (1 week) 1.08M
Average Volume (1 Month) 1.26M
52 Week Change -42.31%
52 Week High 9.875
52 Week Low 3.10
Spread (Intraday) 0.1 (2.63%)

Company Info

Company Name Fusion Antibodies Plc
Address c/o tughans solicitors
belfast BT1 3GG
Website https://www.fusionantibodies.com
Industry pharmaceutical preparations (2834)